234 related articles for article (PubMed ID: 14647110)
41. Antithrombin levels, morbidity, and mortality in a surgical intensive care unit.
Sakr Y; Reinhart K; Hagel S; Kientopf M; Brunkhorst F
Anesth Analg; 2007 Sep; 105(3):715-23. PubMed ID: 17717229
[TBL] [Abstract][Full Text] [Related]
42. A central venous line protocol decreases bloodstream infections and length of stay in a trauma intensive care unit population.
Duane TM; Brown H; Borchers CT; Wolfe LG; Malhotra AK; Aboutanos MB; Ivatury RR
Am Surg; 2009 Dec; 75(12):1166-70. PubMed ID: 19999905
[TBL] [Abstract][Full Text] [Related]
43. Prolongation of hospital stay and additional costs due to nosocomial bloodstream infection in an Algerian neonatal care unit.
Atif ML; Sadaoui F; Bezzaoucha A; Kaddache CA; Boukari R; Djelato S; Boubechou N
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1066-70. PubMed ID: 18826372
[TBL] [Abstract][Full Text] [Related]
44. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
45. [Study of costs associated with catheter-related bacteremia].
Morís de la Tassa J; Fernández Muñoz P; Antuña Egocheaga A; Gutiérrez del Río MC; de la Fuente García B; Cartón Sánchez JA
Rev Clin Esp; 1998 Oct; 198(10):641-6. PubMed ID: 9844450
[TBL] [Abstract][Full Text] [Related]
46. [The estimation of the cost of nosocomial infection in an intensive care unit].
Díaz Molina C; García Martín M; Bueno Cavanillas A; López Luque A; Delgado Rodríguez M; Gálvez Vargas R
Med Clin (Barc); 1993 Mar; 100(9):329-32. PubMed ID: 8455410
[TBL] [Abstract][Full Text] [Related]
47. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
Pittet D; Tarara D; Wenzel RP
JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
[TBL] [Abstract][Full Text] [Related]
48. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay.
Rosenthal VD; Guzman S; Orellano PW
Am J Infect Control; 2003 Aug; 31(5):291-5. PubMed ID: 12888765
[TBL] [Abstract][Full Text] [Related]
49. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
50. The excess cost associated with healthcare-associated bloodstream infections at Auckland City Hospital.
Burns A; Bowers L; Pak NT; Wignall J; Roberts S
N Z Med J; 2010 Oct; 123(1324):17-24. PubMed ID: 20953218
[TBL] [Abstract][Full Text] [Related]
51. Cost evaluation of infections in intensive care.
de Clercq H; De Decker G; Alexander JP; Huyghens L
Acta Anaesthesiol Belg; 1983 Sep; 34(3):179-89. PubMed ID: 6417968
[TBL] [Abstract][Full Text] [Related]
52. Cost and outcomes of nosocomial bloodstream infections complicating major traumatic injury.
Niven DJ; Fick GH; Kirkpatrick AW; Grant V; Laupland KB
J Hosp Infect; 2010 Dec; 76(4):296-9. PubMed ID: 20705364
[TBL] [Abstract][Full Text] [Related]
53. Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: a meta-analysis of time-sequence cohort studies in 4 countries.
Maki DG; Rosenthal VD; Salomao R; Franzetti F; Rangel-Frausto MS
Infect Control Hosp Epidemiol; 2011 Jan; 32(1):50-8. PubMed ID: 21121815
[TBL] [Abstract][Full Text] [Related]
54. [Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs].
Peña C; Pujol M; Pallarés R; Corbella X; Vidal T; Tortras N; Ariza J; Gudiol F
Med Clin (Barc); 1996 Mar; 106(12):441-4. PubMed ID: 8656728
[TBL] [Abstract][Full Text] [Related]
55. Clinical and economic burden of bloodstream infections in critical care patients with central venous catheters.
Brunelli SM; Turenne W; Sibbel S; Hunt A; Pfaffle A
J Crit Care; 2016 Oct; 35():69-74. PubMed ID: 27481738
[TBL] [Abstract][Full Text] [Related]
56. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
57. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
[TBL] [Abstract][Full Text] [Related]
58. Impact of red blood cells transfusion on ICU-acquired bloodstream infections: a case-control study.
Michalia M; Kompoti M; Panagiotakopoulou A; Kallitsi G; Charitidi M; Trikka-Graphakos E; Clouva-Molyvdas PM
J Crit Care; 2012 Dec; 27(6):655-61. PubMed ID: 22386221
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU.
Frank U; Chojnacki T; Dettenkofer M; Daschner FD
Intensive Care Med; 2003 Jan; 29(1):139. PubMed ID: 12528036
[No Abstract] [Full Text] [Related]
60. Excess length of stay due to central line-associated bloodstream infection in intensive care units in Argentina, Brazil, and Mexico.
Barnett AG; Graves N; Rosenthal VD; Salomao R; Rangel-Frausto MS
Infect Control Hosp Epidemiol; 2010 Nov; 31(11):1106-14. PubMed ID: 20923287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
